A little, for some people. In the VITAL trial, 2,000 IU of vitamin D3 a day lowered CRP by 19% at year 2 but not at year 4. Pooled trials found drops mostly in people with blood sugar problems, and none in people with overweight or obesity.
The drop that faded
VITAL is one of the largest vitamin D trials ever run. It gave 25,871 adults in the United States either 2,000 IU of vitamin D a day or a placebo, a dummy pill that looks the same. The men were 50 or older and the women 55 or older.
A smaller group of 1,054 people came in to a Boston research center for blood tests at the start, at year 2 and at year 4. Researchers measured four signals of inflammation. One was hs-CRP, a sensitive test for C-reactive protein, a protein that rises in the blood when there is inflammation. The others were IL-6, IL-10 and TNF-alpha, messenger proteins the immune system uses.
At year 2, the vitamin D group's hs-CRP was 19% lower. That is a real result from a well-run trial.
Then it faded. At year 4, the CRP drop was no longer there, and IL-6, IL-10 and TNF-alpha did not change at either visit. The authors still saw a "potential role" for vitamin D in calming chronic inflammation. We read it as a small, short-lived signal in healthy older adults.
Is vitamin D anti-inflammatory for everyone?
No. Who takes it seems to matter more than anything else.
In VITAL, hs-CRP was 19% lower at year 2, and back where it started by year 4.From a 2022 randomized trial in Nutrients
A 2026 umbrella review, which is a review of other reviews, pulled together 7 meta-analyses covering 97 randomized trials and about 11,600 people. A meta-analysis pools the results of many trials into one answer.
In people whose bodies handle blood sugar poorly, vitamin D lowered CRP, TNF-alpha and IL-6. In type 2 diabetes it lowered hs-CRP and TNF-alpha. An earlier meta-analysis of 20 trials with 1,270 people with type 2 diabetes found the same pattern: lower CRP and TNF-alpha, but no change in IL-6.
People with overweight or obesity were a different story. The umbrella review found no clear change in their inflammation markers, and none in people with asthma either. A 2024 meta-analysis of 11 trials with 504 people with overweight or obesity and low vitamin D found no change in CRP, IL-6 or TNF. That held even in the trials where blood vitamin D clearly went up.
Postmenopausal women may do a bit better. Across 7 studies, vitamin D lowered CRP by 0.65 mg/L on average.
And a 2017 meta-analysis that kept only high-quality trials lasting at least 12 weeks found no effect on IL-6 or CRP. The umbrella review's own authors called the evidence mixed across groups and markers.
Does your starting level matter?
It might. A Mendelian randomization study is a kind of natural experiment. It uses gene variants that nudge vitamin D up or down from birth, so lifestyle is less likely to muddy the answer.
One such study used data from 294,970 people in the UK Biobank. CRP fell sharply as vitamin D rose, but only in people in the deficiency range, below 25 nmol/L. It leveled off at about 50 nmol/L. There was no sign that high CRP was pulling vitamin D down instead. The authors concluded that fixing low vitamin D may reduce chronic inflammation.
That is a lead, not proof. It is a genetic study, not a trial. And the 2024 trials in people with low vitamin D and overweight found no change.
Can vitamin D raise inflammation?
The trials we read do not show a steady rise. One mixed signal is worth knowing. In the 2017 high-quality analysis, trials using under 1,000 IU a day showed higher CRP, while 1,000 IU or more showed lower CRP. Results varied a lot from trial to trial. The 2024 analysis in postmenopausal women found the opposite: doses of 1,000 IU a day or less lowered CRP. Two pooled analyses pointing different ways is noise, not a warning.
What about autoimmune disease?
This is where vitamin D's best result lives. Over a median of 5.3 years in VITAL, 123 people on vitamin D and 155 on placebo were diagnosed with an autoimmune disease, such as rheumatoid arthritis, psoriasis or autoimmune thyroid disease. That was a 22% reduction.
The benefit did not last. Two years after people stopped taking the pills, the protective effect of vitamin D was gone.
What this means for you
Tick what you'll try this week. Your picks stay on this device.
you have kidney disease or kidney stones, you have a condition that affects your calcium levels, you take prescription medicines every day, or you are thinking about a dose well above 2,000 IU a day.
One tap. Results appear once 50 readers have voted, and the count is always real.
The bottom line
A 19% drop that vanished by year 4. Clear changes in people with type 2 diabetes, and none in people with overweight. A genetic study that points at deficiency, and trials in low-vitamin-D adults that found nothing. The big trials do not show vitamin D as a strong anti-inflammatory for most people. They show something smaller and more personal. If your level is low, fixing it is reasonable and worth a talk with your doctor. If it is already normal, a bigger dose is unlikely to move your CRP much.
Common questions
Does vitamin D reduce inflammation in the body?
Sometimes, and mostly in certain groups. A 2026 review of 97 trials found vitamin D lowered CRP, TNF-alpha and IL-6 in people with blood sugar problems, but not in people with overweight or obesity. In the VITAL trial of healthy older adults, hs-CRP was 19% lower at year 2 but not at year 4.
Does vitamin D3 cause inflammation?
The trials we read do not show that. In a 2017 analysis of high-quality trials, doses under 1,000 IU a day showed higher CRP, while doses of 1,000 IU or more showed lower CRP. But a 2024 analysis in postmenopausal women found doses of 1,000 IU or less lowered CRP. With results pointing both ways, there is no steady signal of harm.
Can vitamin D cause inflammation in joints?
None of the trials we read tested joint inflammation from vitamin D directly. In VITAL, the autoimmune diseases counted included rheumatoid arthritis, an inflammatory joint disease. Over 5.3 years, 123 people on vitamin D and 155 on placebo developed an autoimmune disease. That benefit faded within 2 years of stopping.
How long does vitamin D take to lower CRP?
Think months, not days. In postmenopausal women, trials lasting more than 3 months showed a larger CRP drop than the overall result. In the VITAL trial, the 19% drop in hs-CRP showed up at year 2. Trials in people with overweight that ran 2 to 26 weeks found no change.
Ask the Research Desk
Heard something about inflammation you want checked? The best questions become articles, credited by first name only if you say yes.
How this article was made
Researched and written from 9 peer-reviewed papers. Our automated check matched every claim against the exact words of its source, confirmed every paper exists in PubMed, and found none retracted. Checked October 30, 2026. Not individually reviewed by a doctor. Photos are illustrative; the people in them are not patients or readers.
Grades run Strong, Moderate, Emerging, Early and Not supported, and the grade decides the words we may use. How we grade evidence · Medical disclaimer
Sources
- Randomized trialEffects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial.Dong Y, Zhu H, Chen L et al. Nutrients, 2022.PubMedFull paper
- Umbrella reviewThe effects of vitamin D supplementation on inflammatory biomarkers: an umbrella study of meta-analysis on randomized controlled trials.Hsu CY, Hussein HY, Al-Akkam KA et al. Inflammopharmacology, 2026.PubMedFull paper
- Meta-analysisVitamin D supplementation for improvement of chronic low-grade inflammation in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.Mousa A, Naderpoor N, Teede H et al. Nutr Rev, 2018.PubMedFull paper
- Meta-analysisVitamin D supplementation does not alter inflammatory markers in overweight and obese individuals: A systematic review and meta-analysis of randomized controlled trials.Gouveia HJCB, da Silva MM, Manhães de Castro R et al. Nutr Res, 2024.PubMedFull paper
- Meta-analysisThe impact of cholecalciferol supplementation on the systemic inflammatory profile: a systematic review and meta-analysis of high-quality randomized controlled trials.Calton EK, Keane KN, Newsholme P et al. Eur J Clin Nutr, 2017.PubMedFull paper
- StudyVitamin D deficiency and C-reactive protein: a bidirectional Mendelian randomization study.Zhou A, Hyppönen E Int J Epidemiol, 2023.PubMedFull paper
- Randomized trialVitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial.Hahn J, Cook NR, Alexander EK et al. BMJ, 2022.PubMedFull paper
- Randomized trialVitamin D and Marine n-3 Fatty Acids for Autoimmune Disease Prevention: Outcomes Two Years After Completion of a Double-Blind, Placebo-Controlled Trial.Costenbader KH, Cook NR, Lee IM et al. Arthritis Rheumatol, 2024.PubMedFull paper
- Meta-analysisThe Effects of Vitamin D Supplementation on C-Reactive Protein and Systolic and Diastolic Blood Pressure in Postmenopausal Women: A Meta-Analysis and Systematic Review of Randomized Controlled Trials.Jiang Q, Prabahar K, Saleh SAK et al. J Acad Nutr Diet, 2024.PubMedFull paper
